This inventor holds 3 USPTO granted patents. Top assignee: Roussel Uclaf. Active years: 1994-1995.
Company Filing History:
Years Active: 1994-1995
Title: Luc Devocelle: Innovator in Pharmaceutical Chemistry
Introduction
Luc Devocelle is a notable inventor based in Saint Gratien, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of steroid compounds. With a total of 3 patents to his name, Devocelle's work has implications for various therapeutic applications.
Latest Patents
Among his latest patents, Devocelle has developed Lambda-1,4-pregnadiene-3,20-diones. This compound is characterized by a specific formula where R is selected from a group that includes hydrogen, acyl of an organic carboxylic acid of 1 to 8 carbon atoms, allyloxycarbonyl, alkoxycarbonyl, and aralkoxycarbonyl of up to 8 carbon atoms, as well as alkylsulfonyl and arylsulfonyl of up to 8 carbon atoms. These compounds are utilized to prepare substituted 16,17-methylenedioxy-steroids and novel intermediates. Another significant patent is .delta..sup.1,4-pregnadiene-3,20-diones, which shares a similar structural formula and application.
Career Highlights
Luc Devocelle is currently employed at Roussel Uclaf, where he continues to innovate in the pharmaceutical sector. His work focuses on the synthesis and application of steroid compounds, contributing to advancements in medical treatments.
Collaborations
Devocelle collaborates with Philippe Mackiewicz, enhancing the research and development efforts within their field. Their partnership exemplifies the importance of teamwork in driving innovation.
Conclusion
Luc Devocelle's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a key innovator in the industry. His work continues to influence the development of new therapeutic compounds.